Newsroom

Milton Keynes, UK, – 30th April 2025 – MSD Animal Health UK Ltd, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the Veterinary Medicines Directorate has granted the marketing authorisation for BRAVECTO® TriUNO, a new formulation of BRAVECTO (fluralaner) for dogs that targets both external and internal parasites. The monthly, […]

Read more

Milton Keynes,U.K., March 27, 2024 – MSD Animal Health, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK). A study commissioned by MyPet.com, founded by global animal health provider MSD Animal Health, surveyed 2,000 UK cat and dog owners and discovered 81 percent think of their pet as one of the loves of […]

Read more

MILTON KEYNES, U.K., 19th March 2025 – MSD Animal Health UK Limited (a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) has launched a farmer and veterinary focused initiative to showcase how the proactive use of herd monitoring and identification technologies can improve animal health, welfare and productivity. In the first phase […]

Read more

Parasiticide Treatment for Dogs Offers Only Year-Round Flea and Tick Protection Milton Keynes, U.K., 11th March, 2025 – MSD Animal Health, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), has received the S&P Global Animal Health 2024 Best New Companion Animal Product award for the injectable formulation of BRAVECTO® (fluralaner). It is […]

Read more

MILTON KEYNES, U.K., 27 November 2024 – The University of Stirling has announced Laila Al Farsi as the inaugural recipient of the Nikos Steiropoulos Aquaculture Bursary. This prestigious award, sponsored by MSD Animal Health UK, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), supports students with a passion for aquaculture and allows […]

Read more

MILTON KEYNES, U.K., 21st November 2024 – MSD Animal Health UK, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), is delighted to announce the winner and runners up of the MSD Animal Health UK’s Research Bursary Awards Day presentations. Each year, MSD Animal Health UK offers bursaries aimed at veterinary students, veterinary […]

Read more

MILTON KEYNES, U.K., Oct., 28, 2024 – MSD Animal Health UK, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), has called on the UK Government and food supply chain industry to support and promote the use of new technologies to enhance animal health and welfare, to improve production efficiencies, and to safeguard […]

Read more

First vaccine proven to protect calves against Cryptosporidium parvum from the start of colostrum feeding MILTON KEYNES, UK, 14th August – MSD Animal Health (a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) has announced it has received Veterinary Medicines Directorate (VMD) approval for the first vaccine in Great Britain to protect […]

Read more

MILTON KEYNES, U.K., 7th August, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), is pleased to announce that Helene Lanz has taken on the role of General Manager for MSD Animal Health UK and Ireland. Helene brings over 20 years of valuable managerial experience from various roles […]

Read more

MILTON KEYNES, U.K., 5th August 2024 – MSD Animal Health UK Limited (a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) has announced an update to its SenseHub® Dairy Youngstock application plan which makes it fully compatible with all nipple-fed calves from birth. The SenseHub® Dairy Youngstock system uses an electronic ear […]

Read more